Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir) ; a randomized clinical trial

Mohammad Hadi Karbalaie Niya; Erfaneh Movahedi; Mohsen Farrokhpour; Mohamad Taghei Zeiaei; Nima Motamed; Amirhossein Aliakbar; Fatemeh Soleimany; Sajad Karampoor; Gholam Hossein Ashrafi; Fahimeh Safarnezhad Tameshkel; Mitra Ranjbar; Mahin Jamshidi Makiani; Mahdi Yadollahzadeh; Mohana Eskandari; Maryam Roham; Farhad Zamani; Azadeh Laali; Saeed Kalantari; Zeynab Yassin

doi:10.34172/ipp.2022.29270

Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir) ; a randomized clinical trial

Mohammad Hadi Karbalaie Niya
, Erfaneh Movahedi
, Mohsen Farrokhpour
, Mohamad Taghei Zeiaei
, Nima Motamed
, Amirhossein Aliakbar
, Fatemeh Soleimany
, Sajad Karampoor
, Gholam Hossein Ashrafi
, Fahimeh Safarnezhad Tameshkel
, Mitra Ranjbar
, Mahin Jamshidi Makiani
, Mahdi Yadollahzadeh
, Mohana Eskandari
, Maryam Roham
, Farhad Zamani
, Azadeh Laali
, Saeed Kalantari
, Zeynab Yassin

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Immunopathologia Persa
Early online date	10 Sept 2021
DOIs	https://doi.org/10.34172/ipp.2022.29270
Publication status	E-pub ahead of print - 10 Sept 2021

Bibliographical note

Note: This work was supported by Iran University of Medical Sciences.
Tehran, Iran (Grant#98-5-30-17579).

Keywords

Infection and immunology

Access to Document

10.34172/ipp.2022.29270

https://doi.org/10.34172/ipp.2022.29270

Cite this

Karbalaie Niya, M. H., Movahedi, E., Farrokhpour, M., Zeiaei, M. T., Motamed, N., Aliakbar, A., Soleimany, F., Karampoor, S., Ashrafi, G. H., Safarnezhad Tameshkel, F., Ranjbar, M., Jamshidi Makiani, M., Yadollahzadeh, M., Eskandari, M., Roham, M., Zamani, F., Laali, A., Kalantari, S., & Yassin, Z. (2021). Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir) ; a randomized clinical trial. Immunopathologia Persa. Advance online publication. https://doi.org/10.34172/ipp.2022.29270

@article{d60dad2e70684769b904f5c27bd887b5,

title = "Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir) ; a randomized clinical trial",

keywords = "Infection and immunology",

author = "\{Karbalaie Niya\}, \{Mohammad Hadi\} and Erfaneh Movahedi and Mohsen Farrokhpour and Zeiaei, \{Mohamad Taghei\} and Nima Motamed and Amirhossein Aliakbar and Fatemeh Soleimany and Sajad Karampoor and Ashrafi, \{Gholam Hossein\} and \{Safarnezhad Tameshkel\}, Fahimeh and Mitra Ranjbar and \{Jamshidi Makiani\}, Mahin and Mahdi Yadollahzadeh and Mohana Eskandari and Maryam Roham and Farhad Zamani and Azadeh Laali and Saeed Kalantari and Zeynab Yassin",

note = "Note: This work was supported by Iran University of Medical Sciences. Tehran, Iran (Grant\#98-5-30-17579).",

year = "2021",

month = sep,

day = "10",

doi = "10.34172/ipp.2022.29270",

language = "English",

journal = "Immunopathologia Persa",

issn = "2423-8015",

publisher = "Nickan Research Institute",

}

Karbalaie Niya, MH, Movahedi, E, Farrokhpour, M, Zeiaei, MT, Motamed, N, Aliakbar, A, Soleimany, F, Karampoor, S, Ashrafi, GH, Safarnezhad Tameshkel, F, Ranjbar, M, Jamshidi Makiani, M, Yadollahzadeh, M, Eskandari, M, Roham, M, Zamani, F, Laali, A, Kalantari, S & Yassin, Z 2021, 'Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir) ; a randomized clinical trial', Immunopathologia Persa. https://doi.org/10.34172/ipp.2022.29270

TY - JOUR

T1 - Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir) ; a randomized clinical trial

AU - Karbalaie Niya, Mohammad Hadi

AU - Movahedi, Erfaneh

AU - Farrokhpour, Mohsen

AU - Zeiaei, Mohamad Taghei

AU - Motamed, Nima

AU - Aliakbar, Amirhossein

AU - Soleimany, Fatemeh

AU - Karampoor, Sajad

AU - Ashrafi, Gholam Hossein

AU - Safarnezhad Tameshkel, Fahimeh

AU - Ranjbar, Mitra

AU - Jamshidi Makiani, Mahin

AU - Yadollahzadeh, Mahdi

AU - Eskandari, Mohana

AU - Roham, Maryam

AU - Zamani, Farhad

AU - Laali, Azadeh

AU - Kalantari, Saeed

AU - Yassin, Zeynab

N1 - Note: This work was supported by Iran University of Medical Sciences. Tehran, Iran (Grant#98-5-30-17579).

PY - 2021/9/10

Y1 - 2021/9/10

KW - Infection and immunology

U2 - 10.34172/ipp.2022.29270

DO - 10.34172/ipp.2022.29270

M3 - Article

SN - 2423-8015

JO - Immunopathologia Persa

JF - Immunopathologia Persa

ER -